日本語English简体中文 繁體中文

2183 Linical Co.,Ltd.リニカルTSE Standard / Services

0 posts

Linical Co.,Ltd. (2183) at a glance

Code
2183
Company
Linical Co.,Ltd.
Local name
リニカル
Market
TSE Standard
Sector
Services
Share price
¥193 -1.0 (-0.52%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Linical Co.,Ltd. (2183) Stock Price HistoryNear a 52-week low

Linical Co.,Ltd. closed at ¥193 on Nov 20, 2026, −4.0% over 1 month, −35.9% over 1 year.

2026-11-16 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥205¥193Oct 21Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥205Oct 22
1-Month Low¥193Nov 16
1-Week Change−0.5%vs Nov 13
1-Month Change−4.0%vs Oct 19

If you had invested ¥100,000 1 month ago, it would be worth ¥95,074 today (−4.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −12.7%, while this stock moved −4.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥193−1−0.52%
Nov 19 (Thu)¥194−2−1.02%
Nov 18 (Wed)¥196−1−0.51%
Nov 17 (Tue)¥197+4+2.07%
Nov 16 (Mon)¥193−1−0.52%
Nov 13 (Fri)¥194−2−1.02%
Nov 11 (Wed)¥196+0+0.00%
Nov 6 (Fri)¥196−1−0.51%
Nov 5 (Thu)¥197−2−1.01%
Nov 4 (Wed)¥199+1+0.51%
2026-11-16 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥208¥193Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥208Aug 24
3-Month Low¥193Nov 16
1-Month Change−4.0%vs Oct 19
3-Month Change−5.9%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥94,146 today (−5.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −5.9%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥193−1−0.52%
Nov 19 (Thu)¥194−2−1.02%
Nov 18 (Wed)¥196−1−0.51%
Nov 17 (Tue)¥197+4+2.07%
Nov 16 (Mon)¥193−1−0.52%
Nov 13 (Fri)¥194−2−1.02%
Nov 11 (Wed)¥196+0+0.00%
Nov 6 (Fri)¥196−1−0.51%
Nov 5 (Thu)¥197−2−1.01%
Nov 4 (Wed)¥199+1+0.51%
2026-11-16 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥227¥193May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥227May 21
6-Month Low¥193Nov 16
3-Month Change−5.9%vs Aug 20
6-Month Change−14.2%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥85,778 today (−14.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −14.2%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥193−3.5%
Oct 2026¥200−2.4%
Sep 2026¥205−1.0%
Aug 2026¥207+0.5%
Jul 2026¥206+2.0%
Jun 2026¥202−8.2%
May 2026¥220−12.0%
2026-11-16 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥326¥193Nov 21Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥326Jan 15
52-Week Low¥193Nov 16
Year to Date−34.1%vs Dec 30
From 52-Week High−40.8%Jan 15

If you had invested ¥100,000 1 year ago, it would be worth ¥64,120 today (−35.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +16.1%, while this stock moved −35.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥193−3.5%
Oct 2026¥200−2.4%
Sep 2026¥205−1.0%
Aug 2026¥207+0.5%
Jul 2026¥206+2.0%
Jun 2026¥202−8.2%
May 2026¥220−12.0%
Apr 2026¥250−2.7%
Mar 2026¥257−19.9%
Feb 2026¥321+3.2%
Jan 2026¥311+6.1%
Dec 2025¥293−3.6%
Nov 2025¥304―
¥552¥193Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥552Nov 20, 2023
3-Year Low¥193Nov 20, 2026
Annualized Return−29.5%
Max Drawdown−65.0%

If you had invested ¥100,000 3 years ago, it would be worth ¥34,964 today (−65.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −65.0%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥193−34.1%
2025¥293―
¥908¥193Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥908Mar 28, 2022
5-Year Low¥193Nov 20, 2026
Annualized Return−26.3%
Max Drawdown−78.7%

If you had invested ¥100,000 5 years ago, it would be worth ¥21,833 today (−78.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −78.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥193−34.1%
2025¥293―
¥2,488¥123Nov 1, 2008Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥2,488Jun 2018
All-Time Low¥123Dec 2011
Total Change−53.5%vs Nov 2008
Annualized Return−4.2%

If you had invested ¥100,000 in Nov 2008, it would be worth ¥46,506 today (−53.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +537.0%, while this stock moved −53.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥193−34.1%
2025¥293−15.8%
2024¥348−34.3%
2023¥530−23.2%
2022¥690−11.3%
2021¥778+10.2%
2020¥706−37.1%
2019¥1,123−13.1%
2018¥1,292−19.6%
2017¥1,607+27.6%
2016¥1,259−28.4%
2015¥1,759+275.9%
2014¥468−20.0%
2013¥585+52.1%
2012¥385+212.6%
2011¥123−33.3%
2010¥185−41.1%
2009¥313−19.2%
2008¥388―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Nov 2008). Please check the latest prices before trading.

Linical Co.,Ltd. (2183) financial indicators

PER
24.2
PBR
1.36
ROE
5.61%
Dividend yield
4.15%

See all financial indicators for Linical Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Linical Co.,Ltd. (2183)

Business overview

Together with overseas consolidated subsidiaries, the company mainly runs a contract research organization (CRO) business that performs and supports part of the work in clinical trials conducted during drug development. It also runs a post-marketing business supporting clinical trials and research after drugs are launched, and a drug discovery support business providing consulting on development strategy, regulatory affairs and approval applications, offering one-stop global services from drug discovery support through clinical development to post-launch lifecycle management. It has a single segment. In the CRO business, besides its main work of monitoring and quality control, it takes on data management, statistical analysis, medical writing, auditing, and pharmacovigilance covering side effects and other safety information.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Services (532 companies)

Dividend yield4.15%No. 129 in the sector (highest first); median 3.40%
PER24.2xAbove the sector median of 12.9x (No. 372 from the lowest)
PBR1.36xBelow the sector median of 1.49x (No. 234 from the lowest)
ROE5.61%No. 361 in the sector (highest first); median 12.16%
Market cap¥4.4 bnNo. 361 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3261/15
52-week low¥19311/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: ¥193)
Year to date-34.1%No. 452 of 524 in the sector (best first)
1 year-35.9%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (2).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Linical Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English